Bicalutamide, 50 mg 28 pcs

– Monotherapy or adjuvant therapy, in combination with a gonadotropin-releasing hormone (GnRH) analogue or surgical castration, of advanced prostate cancer;

– Treatment of locally advanced prostate cancer (T3-T4, any N, M0, T1-T2, N+, M0) as monotherapy or adjuvant therapy in combination with radical prostatectomy or radiotherapy;

The treatment of locally advanced nonmetastatic prostate cancer in cases where surgical castration or other drugs are not effective or are not acceptable

Active ingredient

Composition

Active substance:

bicalutamide 50 mg;

excipients:

corn starch 35 mg,

croscarmellose sodium (primellose) 6.5 mg,

44.3 mg lactose monohydrate (milk sugar),

povidone 3.2 mg,

sodium stearyl fumarate 1 mg;

coating composition:

Opadray II white 4 mg, including: polyvinyl alcohol 1.6 mg, macrogol (polyethylene glycol) 0.808 mg, talc 0.592 mg, titanium dioxide 1 mg.

How to take, the dosage

Interaction

Special Instructions

Contraindications

Side effects

Overdose

Pregnancy use

Similarities